MedTrace Logo MedTrace
Clinical Trials News Drugs Diseases Companies About

NSCLC

  1. Home
  2. Diseases
  3. NSCLC
  4. Clinical Trials

Clinical Trials Related to NSCLC

Related studies linked through entity extraction aliases.

NCT00283634

A Study of Tarceva for Use in Patients With Relapsed or Refractory Metastatic Non-Small Cell Lung Cancer

Status
TERMINATED
Phase
PHASE2

NCT00280189

Study of Outcomes of Radiofrequency Ablation of Lung Tumors

Status
SUSPENDED
Phase
N/A

NCT00269828

A Survival Study for Women With Advanced Lung Cancer Who Have Not Previously Received Chemotherapy.

Status
TERMINATED
Phase
PHASE3

NCT00259064

Iressa v BSC (Best Supportive Care) in First Line NSCLC

Status
COMPLETED
Phase
PHASE2/PHASE3

NCT00242801

Iressa vs Best Supportive Care - 2nd/3rd Line Survival Study

Status
COMPLETED
Phase
PHASE3

NCT00172380

Phase II Study of Docetaxel Plus CDDP for NSCLC Stage III

Status
COMPLETED
Phase
PHASE2

NCT00153803

Erlotinib or Placebo Following Chemoradiotherapy (Chemo/RT) in Stage III Non-Small Cell Lung Cancer (NSCLC)

Status
COMPLETED
Phase
PHASE3

NCT00082472

Inhaled Doxorubicin Plus IV Docetaxel and Cisplatin in Patients With Non-Small-Cell Lung Carcinoma (NSCLC)

Status
UNKNOWN
Phase
PHASE1/PHASE2

NCT00072618

Phase II Study of Taxotere in Combination With Exisulind in Non-Small Cell Lung Cancer (NSCLC) Patients

Status
COMPLETED
Phase
PHASE1/PHASE2
Previous

Next

Clinical Trials

Explore studies by the year of their last update.

  • 2026
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005

News & Analysis

Latest news and insights on clinical trials and medical research.

Browse All News →
MedTrace Logo MedTrace
About Privacy Policy Terms of Service Medical Disclaimer

© 2026 MedTrace.
Open-access medical & pharmaceutical data intelligence.